Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 22;9(11):1228.
doi: 10.3390/vaccines9111228.

Impact of COVID-19 Disruptions on Global BCG Coverage and Paediatric TB Mortality: A Modelling Study

Affiliations

Impact of COVID-19 Disruptions on Global BCG Coverage and Paediatric TB Mortality: A Modelling Study

Nabila Shaikh et al. Vaccines (Basel). .

Abstract

The impact of COVID-19 disruptions on global Bacillus Calmette-Guérin (BCG) coverage and paediatric tuberculosis (TB) mortality is still unknown. To fill this evidence-gap and guide mitigation measures, we estimated the impact of COVID-19 disruptions on global BCG coverage and paediatric TB mortality. First, we used data from multiple sources to estimate COVID-19-disrupted BCG vaccination coverage. Second, using a static mathematical model, we estimated the number of additional paediatric TB deaths in the first 15 years of life due to delayed/missed vaccinations in 14 scenarios-varying in duration of disruption, and magnitude and timing of catch-up. We estimated a 25% reduction in global BCG coverage within the disruption period. The best-case scenario (3-month disruption, 100% catch-up within 3 months) resulted in an additional 886 (0.5%) paediatric TB deaths, and the worst-case scenario (6-month disruption with no catch-up) resulted in an additional 33,074 (17%) deaths. The magnitude of catch-up was found to be the most influential variable in minimising excess paediatric TB mortality. Our results show that ensuring catch-up vaccination of missed children is a critical priority, and delivery of BCG alongside other routine vaccines may be a feasible way to achieve catch-up. Urgent action is required to support countries with recovering vaccination coverages to minimise paediatric deaths.

Keywords: BCG; COVID-19; immunization; mathematical model; paediatric mortality; tuberculosis.

PubMed Disclaimer

Conflict of interest statement

R.C.H. reports current employment at Sanofi Pasteur, her Sanofi employment includes work on COVID-19, but is unrelated to TB.

Figures

Figure 1
Figure 1
Vaccine coverage scenarios by age in weeks compared to baseline of no disruption; (A) Scenarios A1 to A7 e.g., disruption for 3 months; (B) Scenarios B1 to B7 e.g., disruption for 6 months.
Figure 2
Figure 2
Additional paediatric tuberculosis (TB) deaths from 14 scenarios compared to a baseline of no disruption.

References

    1. World Health Organisation. Gavi. UNICEF At Least 80 Million Children at Risk of Disease as COVID-19 Disrupts Vaccination Efforts, Warn Gavi, WHO and UNICEF. 2020. [(accessed on 19 June 2020)]. Available online: https://www.gavi.org/news/media-room/least-80-million-children-risk-dise....
    1. Chiappini E., Parigi S., Galli L., Licari A., Brambilla I., Tosca M.A., Ciprandi G., Marseglia G. Impact that the COVID-19 pandemic on routine childhood vaccinations and challenges ahead: A narrative review. Acta Paediatr. 2021;110:2529–2535. doi: 10.1111/apa.15949. - DOI - PMC - PubMed
    1. UNICEF UN, Department of Economic and Social Affairs, Population, Division, UNICEF. Geneva Palais Briefing Note on the Impact of COVID-19 Mitigation Measures on Vaccine Supply and Logistics. 2020. [(accessed on 19 June 2020)]. Available online: https://www.unicef.org/press-releases/geneva-palais-briefing-note-impact....
    1. Abubakar I., Pimpin L., Ariti C., Beynon R., Mangtani P., Sterne J., Fine P.E.M., Smith P.G., Lipman M., Elliman D., et al. Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette–Guérin vaccination against tuberculosis. Heal. Technol. Assess. 2013;17:1–372. doi: 10.3310/hta17370. - DOI - PMC - PubMed
    1. Mangtani P., Abubakar I., Ariti C., Beynon R., Pimpin L., Fine P.E.M., Rodrigues L.C., Smith P., Lipman M., Whiting P., et al. Protection by BCG Vaccine Against Tuberculosis: A Systematic Review of Randomized Controlled Trials. Clin. Infect. Dis. 2014;58:470–480. doi: 10.1093/cid/cit790. - DOI - PubMed

LinkOut - more resources